These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Baigent C; Keech A; Kearney PM; Blackwell L; Buck G; Pollicino C; Kirby A; Sourjina T; Peto R; Collins R; Simes R; Lancet; 2005 Oct; 366(9493):1267-78. PubMed ID: 16214597 [TBL] [Abstract][Full Text] [Related]
3. Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels? Simes RJ; Marschner IC; Hunt D; Colquhoun D; Sullivan D; Stewart RA; Hague W; Keech A; Thompson P; White H; Shaw J; Tonkin A; Circulation; 2002 Mar; 105(10):1162-9. PubMed ID: 11889008 [TBL] [Abstract][Full Text] [Related]
5. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Pyŏrälä K; Pedersen TR; Kjekshus J; Faergeman O; Olsson AG; Thorgeirsson G Diabetes Care; 1997 Apr; 20(4):614-20. PubMed ID: 9096989 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of statin therapy in adults with coronary heart disease. Wilt TJ; Bloomfield HE; MacDonald R; Nelson D; Rutks I; Ho M; Larsen G; McCall A; Pineros S; Sales A Arch Intern Med; 2004 Jul; 164(13):1427-36. PubMed ID: 15249352 [TBL] [Abstract][Full Text] [Related]
7. Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study. Athyros VG; Mikhailidis DP; Papageorgiou AA; Symeonidis AN; Daskalopoulou SS; Kakafika AI; Pehlivanidis AN; Bouloukos VI; Langer A; Curr Med Res Opin; 2004 Sep; 20(9):1385-92. PubMed ID: 15383187 [TBL] [Abstract][Full Text] [Related]
8. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study. Strandberg TE; Feely J; Sigurdsson EL; Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694 [TBL] [Abstract][Full Text] [Related]
9. The relationship between low-density lipoprotein cholesterol goal attainment and prevention of coronary heart disease--related events. Ito MK; Delucca GM; Aldridge MA J Cardiovasc Pharmacol Ther; 2001 Apr; 6(2):129-35. PubMed ID: 11509919 [TBL] [Abstract][Full Text] [Related]
10. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up. LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease) Lancet; 2002 Apr; 359(9315):1379-87. PubMed ID: 11978335 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. ; Baigent C; Blackwell L; Emberson J; Holland LE; Reith C; Bhala N; Peto R; Barnes EH; Keech A; Simes J; Collins R Lancet; 2010 Nov; 376(9753):1670-81. PubMed ID: 21067804 [TBL] [Abstract][Full Text] [Related]
12. Statin trials and goals of cholesterol-lowering therapy after AMI. Pedersen TR Am Heart J; 1999 Aug; 138(2 Pt 2):S177-82. PubMed ID: 10426879 [TBL] [Abstract][Full Text] [Related]
13. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. Cziraky MJ; Watson KE; Talbert RL J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279 [TBL] [Abstract][Full Text] [Related]
14. Reduction in serum total cholesterol and risks of coronary events and cerebral infarction in Japanese men: the Kyushu Lipid Intervention Study. Sasaki J; Arakawa K; Iwashita M; Matsushita Y; Kono S; Circ J; 2003 Jun; 67(6):473-8. PubMed ID: 12808261 [TBL] [Abstract][Full Text] [Related]
15. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study. Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A; Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888 [TBL] [Abstract][Full Text] [Related]
16. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S). Miettinen TA; Pyörälä K; Olsson AG; Musliner TA; Cook TJ; Faergeman O; Berg K; Pedersen T; Kjekshus J Circulation; 1997 Dec; 96(12):4211-8. PubMed ID: 9416884 [TBL] [Abstract][Full Text] [Related]